Alliance Pharma buy-and-build strategy working
Diclectin is entering a potential £250mln UK/European market with a differentiated product addressing an unmet need.
Company
LON:APH
Alliance Pharma PLC is an international healthcare group, headquartered in the UK with subsidiaries in Europe, the Far East and the US and wide international reach through an extensive network of distributors, generating sales in more than 100 countries. The company holds marketing rights to around 80 Consumer Healthcare brands and Prescription Medicines, which are managed on a portfolio basis according to their growth potential.
156 stories · page 2 of 2
Diclectin is entering a potential £250mln UK/European market with a differentiated product addressing an unmet need.
Archive
A glance at some of the stories on the Proactive newswire today
Archive
A glance at some of the stories on the Proactive newswire today
Some of the largest risers and fallers in London at 3.15pm
Diclectin is expected to receive UK regulatory approval in the third quarter
FlowGroup has selected a preferred bidder for its microcho boiler business. Also Versarien and Bahamas Petroleum.
A compensation payment of £4mln is now due from Sinclair on or before 30 April 2017, with a further £1mln due on or before 30 June 2018.
Inflation jumped to 2.3% in February raising the prospect of higher interest rates
Archive
Kibo Mining confident of Mbeya progress after bankable study; Providence Resources due to start Druid exploration well in June; Alliance Pharma sales double, profits in line with forecast; and more…
The specialty pharma company said it expects sales to be £97.5mln for the 12 months ended December 31, up from £48.3mln a year earlier.
He is already chief commercial officer and joined the board in February 2010
A round up of the day's news from Proactive Investors.
John Dawson still owns more than 56mln shares in the specialty pharmaceutical company, worth around £25mln
Alliance acquired the Sinclair Healthcare Products business in December last year, which made an immediate contribution to first half results
Diclectin has been used by pregnant women in Canada for over 30 years
Sinclair Pharma plc expects to shave its annual costs by £2mln as it launched a "comprehensive" staff restructuring programme.
Alliance Pharma has doubled its sales after last year’s acquisition; Solo Oil gets some more good news from Horse Hill; DP Poland enjoyed a strong first half; plus much more…
Alliance's swoop for Sinclair Healthcare Products in December helped it rack up first-half sales of £46.4mln
Speciality drug company benefits from last year's acquisition of Sinclair Healthcare Products
Numis said that the recent weakness in Sterling gives the group additional firepower to reinforce its international pricing position
Youth-orientated fashion firms ASOS and Supergroup go head to head, while a bit further up-market Burberry may regard the Brexit fall-out as a mixed blessing
The Sinclair acquisition took effect from December 17 and in the few days until the end of the year, it contributed £0.8mln to group sales.
"Kelo-Cote, our scar reduction product from the Sinclair portfolio, is now our largest-selling brand,”
Archive
Better news for Westminster group, a 'transformational' year for Alliance Pharma and Victoria Oil & Gas secures government approval.
Alliance Pharma reported a robust final statement after a “transformational” year for the pharmaceuticals group.
The February trading update sent analysts scurrying to their calculators to upgrade their forecasts
Archive
UK equities were in good shape even before ECB president Draghi started sweet-talking the market
Archive
Small cap news today from the Proactive Investors universe
The benchmark FTSE 100 Index climbed 21 points to 5,696
Group revenue for 2015 was £48.2 mln (£43.5mln), up 10%
Archive
Unusually, the majority of the big gains today were to be found among the FTSE 350 - especially the FTSE 100
Archive
A round-up of the day's company news from the small cap universe
Archive
For once, technology firms crowd out resource companies in our round-up of the main news from growth companies
UK shares hit highest in a fortnight while German stocks touched three-month highs
Britain's blue-chips keep legal eagles busy; Topshop seeks to fatten the bottom line with Beyoncé; DMGT offloads Wowcher
Investments and investor services
FTSE 100 Index rises 21.58 points to 6359 on eurozone bank lending cheer
Below are the main news-driven share price movements at 4pm.
The deal will allow Alliance to enter or expand in markets such as the US and Asia Pacific
Archive
There were some fireworks at Proactive today... Alliance Pharma shares nudged higher on Thursday after it emerged it will receive £6.7mln in compensation.....
The £6.7mln will paid in cash and is inclusive of costs.
The impending return of ImmuCyst, a bladder cancer treatment, following a three year absence is one of the drivers as is a new product, Diclectin.
Archive
Medtechs were in focus today, as were mining companies
Sales in the half year to June were £22.8mln (£21.4mln), while profits edged up to £5.5mln (£5.4mln).
House builders are in focus again - with Barratt Developments....
Archive
Shares in Jubilee Platinum soared today on disposal news....
Richard Wright, who had been at Alliance Pharma since 2007 before leaving at the end of May, will join Sphere from August 10.
Investments and investor services
There was a lot of news in the world of small caps today, starting with Tethys Petroleum
Sales in the half year to June were £22.8m or 6.5% ahead of a year ago.
Archive
On the day of the Queens speech a mixed news bag, which featured miners, biotechs and tech stocks.